Is elevated microsatellite alterations at selected tetranucleotide repeats (EMAST)-negative/MSI-high colorectal cancer a distinct subtype of the disease?
Yeshong ParkDuck-Woo KimYun Ji HongKyoung Un ParkSoo Kyung NamHee Young NaHye Seung LeeMin Hyun KimHeung-Kwon OhSung-Bum KangPublished in: Journal of surgical oncology (2020)
Patients with EMAST-negative/MSI-H CRC seem to have different clinicopathological characteristics. Future large-scale studies could clarify the role of EMAST genotype as a sub-classifier of MSI-H CRC.
Keyphrases